Analystreport

Jounce Therapeutics, Inc. (NASDAQ: JNCE) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $7.00 pri

Jounce Therapeutics, Inc.  (JNCE) 
Last jounce therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.jouncetx.com